Health

Source link : https://www.newshealth.biz/health-news/brain-changes-emerge-decades-before-huntingtons-diagnosis/ Cerebrospinal fluid analysis revealed elevated neurofilament light protein and proenkephalin levels 23 years before clinical diagnosis of Huntington’s disease. Brain imaging showed atrophy in the caudate and putamen at this time point. A longitudinal increase in the somatic cytosine-adenine-guanine repeat expansion ratio in blood predicted brain atrophy. Changes in cerebrospinal fluid (CSF) neurofilament light (NfL) […] […] More

Source link : https://www.newshealth.biz/health-news/rheumatologist-accused-of-sex-abuse-by-over-200-patients-is-indicted-on-rape-charges/ A grand jury in Massachusetts has indicted a rheumatologist who is accused of sexually assaulting more than 200 former patients over a period of more than a decade. The patients sued Derrick Todd, MD, who has been accused of performing unnecessary pelvic floor therapy, breast examinations, testicular examinations, and other unwarranted procedures on patients dating […] […] More

Source link : https://health365.info/ai-is-helping-expect-reminiscence-problems-cognitive-decline-throughout-menopausal-transition/ Synthetic intelligence could possibly extra temporarily and cost effectively determine menopausal ladies who’re having issues of reminiscence or cognition. AI successfully recognized ladies with critical subjective cognitive decline (SCD), or self-perceived confusion or reminiscence issues, researchers document in a brand new find out about printed within the magazine Menopause. The use of AI to assist menopausal […] More

Source link : https://www.newshealth.biz/health-news/fda-approves-new-adc-for-hr-her2-breast-cancer/ The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. Specifically, the novel Trop-2-directed antibody and topoisomerase inhibitor conjugate is indicated for those who have received prior treatment with endocrine-based therapy and […] […] More

Source link : https://health365.info/learn-about-exhibits-ais-transformative-influence-on-icu-care-with-smarter-predictions-and-clear-insights/ Credit score: Pixabay/CC0 Public Area Extensive care gadgets (ICUs) face mounting drive to successfully arrange sources whilst handing over optimum affected person care. Groundbreaking analysis revealed within the magazine Knowledge Methods Analysis highlights how a unique synthetic intelligence (AI) style is revolutionizing ICU care by way of now not handiest making improvements to predictions of affected […] More

Source link : https://www.newshealth.biz/health-news/fda-approves-datroway-for-pretreated-advanced-breast-cancer/ The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease. Efficacy of the Trop2-directed antibody and topoisomerase inhibitor conjugate was evaluated in the multicenter TROPION-Breast01 trial, which included 732 patients randomized to datopotamab deruxtecan or […] […] More

Source link : https://health365.info/pandemic-resulted-in-instant-adoption-of-telemental-fitness-for-the-ones-with-schizophrenia/ For Medicaid beneficiaries with schizophrenia, supply of psychological fitness care via telehealth (telemental fitness care) subtle all of a sudden after onset of the COVID-19 pandemic, in keeping with a find out about printed on-line Jan. 16 in JAMA Community Open. Sharon-Lise Normand, Ph.D., from Harvard Clinical Faculty in Boston, and associates performed a retrospective cohort […] More

Source link : https://www.newshealth.biz/health-news/dont-call-it-cancer-clues-to-exceptional-responses-more-predictions-for-2025/ More debate about whether the lowest-risk prostate cancers should even be called “cancer.” (Harvard Health Publishing) Four cancer drugs — palbociclib (Ibrance), enzalutamide (Xtandi), pomalidomide (Pomalyst), and acalabrutinib (Calquence) — were selected by the Biden administration for the next round of Medicare drug price negotiation. Atara Biotherapeutics acknowledged receipt of a complete response letter from […] […] More

Source link : https://health365.info/ai-can-information-acquisition-of-diagnostic-quality-lung-ultrasound-pictures/ Educated well being care execs (THCPs), together with clinical assistants, breathing therapists, and nurses, with synthetic intelligence (AI) help can reach lung ultrasound (LUS) pictures with diagnostic high quality that doesn’t fluctuate considerably from that completed through professionals, in step with a learn about printed on-line Jan. 15 in JAMA Cardiology. Cristiana Baloescu, M.D., M.P.H., from […] More

Source link : https://www.newshealth.biz/health-news/children-with-ibd-showed-impaired-growth-before-diagnosis/ Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index (BMI) in the years before diagnosis, particularly those with Crohn’s disease, a Danish population-based cohort study showed. Compared with children without IBD, those with a diagnosis of Crohn’s disease had declining anthropometric measures 3 years before […] […] More

Source link : https://health365.info/cdc-urges-quicker-checking-out-for-chicken-flu-amid-rising-outbreak/ The U.S. Facilities for Illness Keep an eye on and Prevention (CDC) is urging well being care employees to boost up chicken flu checking out for sufferers hospitalized with flu signs, because the H5N1 avian influenza outbreak continues to develop in the USA and Canada. The advisory, issued Jan. 16, recommends that well being care suppliers […] More

Source link : https://www.newshealth.biz/health-news/adding-palbociclib-to-standard-care-improved-pfs-in-triple-positive-breast-cancer/ Findings from the phase III PATINA trial, presented at the San Antonio Breast Cancer Symposium, showed that adding the CDK4/6 inhibitor palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy significantly extended progression-free survival (PFS) by nearly 15 months in patients with hormone receptor-positive, HER2-positive metastatic breast cancer. In this exclusive MedPage Today video, Gaia […] […] More